| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/30/2001 | CN1297350A Agents for relieving side effects |
| 05/30/2001 | CN1296850A Formulations of 23 medicines |
| 05/30/2001 | CN1296841A Extract of Chinese-medicinal herbs and its application |
| 05/30/2001 | CN1296837A Chinese patent medicine for treating peptide ulcer |
| 05/30/2001 | CN1296835A Exterior applied liquid Chinese medicine for treating diarrhea |
| 05/30/2001 | CN1296831A Capsule for converting to negative for hepatitis B and its preparing process |
| 05/30/2001 | CN1296828A Medicine for treating hepatobiliary disease and its preparing process |
| 05/30/2001 | CN1296825A Capsule or tablet for treating viral hepatitis |
| 05/30/2001 | CN1296824A Weishukang for treating gastrosis |
| 05/30/2001 | CN1296821A Medicine for treating hepatism and its preparing process |
| 05/30/2001 | CN1296820A Gansu julid tablet for gastrosis and its preparing process |
| 05/30/2001 | CN1066449C Tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions contg. them |
| 05/30/2001 | CN1066446C 4-amino-3-acylnaphthyridine derivs. |
| 05/30/2001 | CN1066445C Aroyl-piperidine derivs. |
| 05/30/2001 | CN1066341C Chinese medicine for treating hepatitis B and preparing process thereof |
| 05/30/2001 | CN1066340C Use of theaflavine for preparing medicine for treating enterogastric diseases |
| 05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
| 05/29/2001 | US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
| 05/29/2001 | US6239131 1,5 Benzodiazepine derivatives |
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | CA2195923C Azetidines |
| 05/29/2001 | CA2091506C Thieno[3,2-b]pyridine derivatives |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036510A2 Use of poly(diallylamine) polymers |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036451A1 Vitamin e derivatives |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036425A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 05/25/2001 | WO2001036422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | WO2001036420A1 Tricyclic azaindolizine derivatives having an spla2- inhibiting effect |
| 05/25/2001 | WO2001036417A1 New use and novel n-azabicyclo-amide derivatives |
| 05/25/2001 | WO2001036409A1 Magnesium omeprazole |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036398A1 Benzoxa- and benzthiazoles |
| 05/25/2001 | WO2001036395A1 Triazoles as farnesyl transferase inhibitors |
| 05/25/2001 | WO2001036385A1 Hydroxyethoxybenzamide derivatives and drugs containing the same |
| 05/25/2001 | WO2001036376A1 Novel phenylalanine derivatives |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/25/2001 | WO2001035987A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | WO2001035943A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 05/25/2001 | WO2001035899A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 05/25/2001 | WO2001013905A3 Methods for the treatment of mental and vascular disorders |
| 05/25/2001 | WO2000061191A3 Heat stable coated colloidal iron oxides |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2391889A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | CA2391291A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | CA2391087A1 Imidazole compounds as phosphodiesterase vii inhibitors |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2389604A1 New use and novel n-azabicyclo-amide derivatives |
| 05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
| 05/25/2001 | CA2388777A1 18 human secreted proteins |
| 05/24/2001 | US20010001711 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/23/2001 | EP1101769A2 Nitrogen Containing Erythromycin Derivatives |
| 05/23/2001 | EP1101759A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100767A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100532A2 Methods of using lanreotide, a somatostatin analogue |
| 05/23/2001 | EP1100505A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100502A1 Methods and compositions for treating gastro-esophageal reflux disease |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100488A1 Use of creatine compounds for treatment of bone or cartilage cells and tissues |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100481A2 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |
| 05/23/2001 | EP1100469A1 Rapidly disintegrable solid preparation |
| 05/23/2001 | EP0900218A4 Heterocyclic compounds |
| 05/23/2001 | EP0812835B1 Optically active thiazolidinone derivatives |